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Abstract  
The bone health is an important part of healthy-life and longevity in general. The present study was investigated to see 
the effect of the Biofield Energy Healing (The Trivedi Effect®) on the human bone osteosarcoma cells - MG-63 (ATCC® 
CRL-1427™) for the assessment of bone cell proliferation and differentiation in vitro. The study parameters were assessed 
using cell viability by MTT, collagen synthesis, and alkaline phosphatase (ALP) on bone health using ELISA-based assay. 
The cell viability assay data showed significant response in all the tested groups; while in the Biofield Energy Treated 
group supplemented with 10% charcoal-dextran treated fetal bovine serum (CD-FBS) (G3) showed better response 
(increased 63%) in terms of cells proliferation compared to the untreated cell group (G1). The level of ALP was increased 
by 32% in the G3 group compared to the untreated cells group (G1). Additionally, the level of collagen synthesis was 
increased by 27% in the G3 group compared to the G1 group. The overall results demonstrated that the Biofield Energy 
Treatment has the potential for bone mineralization and bone growth as evident via increased levels of collagen and ALP. 
Therefore, the Biofield Energy Healing (The Trivedi Effect®) Treatment might be useful as a bone health promoter for 
various bone-related disorders like low bone density, osteogenesis imperfecta, and osteoporosis.  
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Abbreviations: MTT: 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide; PBS: Phosphate buffer 
saline; ELISA: Enzyme-linked immunosorbent assay; CD-
FBS: Charcoal-dextran treated fetal bovine serum; ALP: 
Alkaline phosphatase; NCCAM: National Center for 
Complementary and Alternative Medicine. 
Introduction 
Bone formation needs differentiated and active 
osteoblasts for the synthesis the extracellular matrix, 
which enhanced the process of mineralization [1]. The 
human osteosarcoma cell line (MG-63) has been used to 
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study the production of the bone-specific protein, 
osteocalcin. In the absence of any stimuli, MG-63 cells 
secreted very low level of osteocalcin [2]. From the 
literature, it was indicated that parathyroid hormone 
(PTH) and prostaglandin E2 (PGE2) inhibits osteocalcin 
secretion by a mechanism involving cAMP production. In 
contrast, an increase in extracellular calcium, which 
stimulate osteocalcin release. The regulation of 
osteocalcin secretion is mediated by the PTH and PGE2 in 
normal human bone cells, which can be produced in the 
human osteoblast-like cell line MG-63. Both cell cultures 
showed time- and dose-dependent stimulation of 
osteocalcin secretion in response to 1,25-
dihydroxyvitamin D3 (1,25(OH)2D3) active form of 
vitamin D3. Thus the human osteosarcoma cell line MG-63 
is useful as an alternative osteoblast-like cell model to 
study the regulation of osteocalcin secretion [3]. Alkaline 
phosphatase (ALP) has many different functions in the 
many organisms and tissues and plays a major role in 
mineralization of bone tissues. More than 80 years ago, 
the high level of ALP expression in bone was observed 
indicating it’s important for hard tissue formation. 
Scientific research demonstrated that ALP had increased 
the local concentration of inorganic phosphate (Pi), a 
concept known as the ‘booster hypothesis’ [4]. Different 
types of approaches such as molecular, biochemical, 
histochemical, and ultrastructural have been studied for 
the establishment of a temporal sequence of gene 
expression associated with the development of the bone 
cell phenotype in primary osteoblast cultures. The peak 
levels of expressed genes reflect a developmental 
sequence of bone cell differentiation characterized by 
three principal periods: proliferation, extracellular matrix 
maturation and mineralization [5]. ALP can plays a key 
role in the process of bone mineralization. It is expressed 
in both bone and calcifying cartilage, an early stage of 
bone development. Later on, other gene (e.g. osteocalcin) 
is upregulated and simultaneously ALP expression had 
declined. ALP mainly acts in the initial phases of the 
mineralization process. The mechanisms though which 
ALP expression regulated are complex; a web of interlaced 
signaling pathways, controlling osteoblastic 
differentiation, chondrogenesis and ALP expression are 
the BMP/RUNX2 (CBAf1, AML3)/ Osterix system, and the 
WNT signaling cascade, which also interact with each 
other [6,7]. In today’s world, Energy Therapy like Biofield 
Energy Healing has been widely used and recommended 
as an alternative method that has an impact on various 
properties of living organisms in a cost-effective manner 
[8]. The Trivedi Effect® - Biofield Energy Healing has been 
known to improve the potential beneficial effects in a 
broad spectrum field around the Globe. It improved the 
overall productivity of crops in agriculture and livestock 
[9-12], positive impact on cancer [13,14], and altered 
characteristics features of microbes in the field of 
microbiology [15-18]. It also alters the structural, 
physical, and thermal properties of several metals and 
ceramics [19-21], causes genetic alteration in microbes 
[22,23], and improves various nutraceutical compounds 
in the areas of nutraceuticals [24,25] and biotechnology 
[26-28]. Many treatment strategies are available for the 
proliferation and differentiation of bone cells using 
synthetic drugs and chemicals. However, due to its high 
cost, anticipated toxicity, render it undesirable for the 
patients. Based on the impact of The Trivedi Effect® in 
various field, authors intended to explore the study of the 
Biofield Energy Healing on bone health in in vitro cellular 
model i.e., human bone osteosarcoma cells - MG-63. 
Therefore, authors investigated the effect of Biofield 
Energy Healing (The Trivedi Effect®) on the human bone 
osteosarcoma cells - MG-63 (ATCC® CRL-1427™) for the 
assessment of bone proliferation and differentiation in 
vitro. 
 
Materials and Methods 
Chemicals and Reagents 
Antibiotics solution (penicillin-streptomycin) and 
DMEM (phenol-red free) were procured from HiMedia, 
India. DMEM was procured from GIBCO, USA. Direct Red 
80, 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-
tetrazolium) (MTT), and β-estradiol (positive control) 
were purchased from Sigma Chemical Co. St. Louis, MO, 
USA. All the other chemicals used in this experiment were 
analytical grade procured from India. 
 
Cell Culture and Maintenance 
Human bone osteosarcoma cell line -MG-63 (ATCC® 
CRL-1427™) was used as test system in the present study. 
MG-63 cell line was maintained under DMEM growth 
medium for routine culture supplemented with 10% FBS. 
Growth conditions were maintained at 37°C, 5% CO2, and 
95% humidity and subcultured by trypsinisation followed 
by splitting the cell suspension into fresh flasks and 
supplementing with fresh cell growth medium. Three 
days before the start of the experiment (i.e., day -3), the 
growth medium of near-confluent cells was replaced with 
fresh phenol-free DMEM, supplemented with 10% 
charcoal dextran stripped FBS (CD-FBS) and 1% 
penicillin-streptomycin [29]. 
 
Biofield Energy Healing Approach 
An aliquot of MG-63 cells in a T-25 cell culture flask 
received Biofield Energy Treatment (The Trivedi Effect®) 
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under laboratory conditions for ~3 minutes from a 
distance of ~25 cm, at day 0. The energy transmission 
was done without touching the cells. Following Biofield 
Energy Treatment, the above T-25 flask was incubated for 
48 hours with defined conditions along with the 
untreated cells.  
 
Experimental Design 
The tested cells were divided into three groups. Group 
1 served as baseline control (untreated cells with 200 µL 
of phenol-free DMEM supplemented with 10% CD-FBS). 
Group 2 served as positive control (untreated cells + 180 
µL of phenol-free DMEM with 10% CD-FBS + β-estradiol 
at three different concentrations such as 1, 10, and 100 
nM). Group 3 was received Biofield Energy Treated cells 
in phenol-free DMEM medium supplemented with 10% 
CD-FBS.  
 
Assessment of Cell Proliferation 
The Biofield Energy Treated MG-63 cells as well as the 
untreated MG-63 cells were trypsinized, counted, and 
plated in wells of flat bottom in 96-well plates at the 
density corresponding to 5 X 103 cells/well/180 µL of 
growth medium. Following respective treatments, the 
cells in the 96-well plates were incubated for 48 hours in 
a CO2 incubator at 37°C, 5% CO2, and 95% humidity. After 
48 hours of incubation, the plate was taken out and 20 µL 
of 5 mg/mL of MTT solution was added to all the wells 
followed by additional incubation for 3 hours at 37°C. The 
supernatant was aspirated and 150 µL of DMSO was 
added to each well to dissolve formazan crystals. The 
absorbance of each well was read at 540 nm using 
Synergy HT microplate reader [30]. The percentage cell 
growth corresponding to each treatment was calculated 
using formula (1): 
 
% Cell growth = [[(X-Tz)/(R-Tz)] x 100].....................(1) 
 
Where, X = Absorbance of cells corresponding to positive 
control and test groups after 48 hours 
R = Absorbance of cells corresponding to baseline group 
after 48 hours 
Tz = Absorbance of untreated cells at time 0 hour  
Positive control was run in parallel to the sample. 
Concentrations were determined, and the experiment was 
done in triplicates. 
 
Assessment of Alkaline Phosphatase (ALP) 
Activity 
The Biofield Energy Treated MG-63 cells as well as 
untreated MG-63 cells were trypsinized, counted and 
plated in wells of flat bottom 96-well plates at the density 
corresponding to 10 X 103 cells/well/180 µL of growth 
medium. Following respective treatments, the cells in the 
above plate were incubated for 48 hours in a CO2 
incubator at 37°C, 5% CO2, and 95% humidity. After 48 
hours of incubation, the plate was taken out and 
processed for measurement of ALP enzyme activity. The 
cells were washed with 1X PBS and lysed by freeze-thaw 
method i.e., incubation at -80°C for 20 minutes followed 
by incubation at 37°C for 10 minutes. To the lysed cells, 
50 µL of substrate solution i.e., 5 mM of p-nitrophenyl 
phosphate (pNPP) in 1M diethanolamine and 0.24 mM 
magnesium chloride (MgCl2) solution (pH 10.4) was 
added to all the wells followed by incubation for 1 hour at 
37°C. The absorbance of the above solution was read at 
405 nm using Synergy HT microplate reader (Biotek, 
USA). The absorbance values obtained were normalized 
with substrate blank (pNPP solution alone) absorbance 
values. The percentage increase in ALP enzyme activity 
with respect to the untreated cells (baseline group) was 
calculated using formula (2): 
 
% Increase = [(X-R)/R)]*100.........................(2) 
 
Where,  X = Absorbance of cells corresponding 
to positive control and test groups 
   R = Absorbance of cells corresponding 
to baseline group (untreated cells) 
 
Assessment of Collagen Synthesis  
The Biofield Energy Treated MG-63 cells as well as 
untreated MG-63 cells were trypsinized, counted and 
plated in wells of 48-well plates at the density 
corresponding to 10 X 103 cells/well/0.5 mL of growth 
medium. Following respective treatments, the cells in the 
above plate were incubated for 48 hours in a CO2 
incubator at 37°C, 5% CO2, and 95% humidity. After 48 
hours of incubation, the plate was taken out and the 
amount of collagen accumulated in MG-63 cells 
corresponding to each treatment was measured by Direct 
Sirius red dye binding assay. In brief, the cell layers were 
washed with PBS and fixed in Bouin’s solution (5% acetic 
acid, 9% formaldehyde and 0.9% picric acid) for 1 hour at 
room temperature (RT). After 1 hour of incubation, the 
above wells were washed with milliQ water and air dried. 
The cells were then stained with Sirius red dye solution 
for 1 hour at RT followed by washing in 0.01 N HCl to 
remove unbound dye. The collagen dye complex obtained 
in the above step was dissolved in 0.1 N NaOH and 
absorbance was read at 540 nm using Biotek Synergy HT 
microplate reader. The level of collagen was extrapolated 
using standard curve obtained from purified Calf Collagen 
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Bornstein and Traub Type I (Sigma Type III). The 
percentage increase in collagen level with respect to the 
untreated cells (baseline group) was calculated using 
formula (3): 
 
% Increase = ((X-R)/R)*100................................(3) 
 
Where, X = Collagen levels in cells corresponding to 
positive control and test groups 
R = Collagen levels in cells corresponding to baseline 
group (untreated cells) 
 
Statistical Analysis 
Data analysis was performed with SigmaPlot Statistical 
Software (Version 11.0). Differences between means (in 
triplicates) were assessed for statistical differences using 
one-way analysis of variance (ANOVA) and post-hoc 
analysis was done by Dunnett’s test. p≤0.05 was 
statistically significant. The results are shown as mean ± 
standard deviation (SD). 
 
Results 
Assessment of Cells Viability by MTT Assay 
The effect of the Biofield Energy Healing on the 
proliferation of human bone osteosarcoma cell was 
examined after 48 hours using MTT assay are shown in 
Table 1. The cell viability was significantly (p≤0.001) 
increased by 63% in the Biofield Energy Treated cells 
supplemented with 10% CD-FBS (G3) compared to the 
untreated cells (G1). The cell viability in the positive 
control group (G2) was significantly increased by 19%, 
68%, and 53% at the concentration of 1, 10, and 100 nM, 
respectively compared to the G1 group. The cell viability 
was significantly increased in all the tested groups 
compared to the untreated cells group (G1).  
 
Group 
G1 G2 
Time (T0) Time (72h) 1 nM 10 nM 100 nM G3 
Absorbance 
0.527 ± 0.054 0.910 ± 0.034 0.984 1.170 ± 0.101 1.114 ± 0.033 1.150 ± 0.048 
  
± 
   
  
0.041 
   
% Cell Proliferation w.r.t. T0 0 100 119 168*** 153*** 163* 
G1: Untreated cells; G2: Positive control (β-Estradiol) at the concentrations of 1, 10 and 100 nM. G3: Biofield Energy 
Teated cells. All the groups were included phenol-free DMEM supplemented with 10% CD-FBS. Values are represented as 
mean ± SD and the experiment was carried out in triplicates. ***p≤0.001 vs G1 (using one-way ANOVA). 
Table 1: Effect of the Biofield Energy Treatment on human bone osteosarcoma cell for the assessment of cell proliferation 
by MTT assay measured at 540 nM.  
 
Assessment of Alkaline Phosphatase (ALP) 
Activity  
Effect of the Biofield Energy Treatment on the level of 
alkaline phosphatase (ALP) in human bone osteosarcoma 
cell is presented in Table 2. The absorbance level of ALP 
in the untreated cells (G1) was 0.212 ± 0.031. Besides, the 
level of ALP was significantly increased by 32% in the 
Biofield Energy Treated group (G3) supplement with 10% 
charcoal-dextran treated fetal bovine serum (CD-FBS) 
compared to the G1 group. The positive control (β-
estradiol) group (G2) showed a significantly increased the 
level of ALP by 38%, 35%, and 29% at the concentrations 
of 1, 10, and 100 nM, respectively compared to the G1 
group (Table 3). Overall, the Biofield Energy Treated 
group (G3) that are supplemented with CD-FBS showed 
an improved the level of ALP in the human osteosarcoma 
cells with respect to the untreated group (G1). ALP are 
membrane-bound ectoenzymes. Human ALP is classified 
into 4 type’s tissue nonspecific, intestinal, placenta, and 
germ cell. The tissue non-specific type of ALP is 
ubiquitously expressed in many tissues, including liver, 
bone, and kidney, and known as liver bone kidney (LBK) 
type [31]. The LBK type of ALP is expressed on the cell 
membrane of hypertrophic chondrocytes, osteoblasts, and 
odontoblasts. The mechanism in which this enzyme 
carries out its function to act both to increase the local 
concentration of inorganic phosphate (Pi), a 
mineralization promoter, and to decrease the 
concentration of extracellular pyrophosphate (PPi), an 
inhibitor of mineral formation [32]. Based on the lots of 
literatures it has been clear that ALP plays a vital role for 
bone health, osteogenesis, and calcification process. The 
enzymes split-up organic phosphate to formed Pi, which 
thus combined with soluble calcium ion present in the 
tissue fluids and formed calcium phosphate. After 
reaching sufficient concentration of calcium phosphate it 
chemically precipitated into osteoid [33,34]. In this 
experiment, it was also evident that the Biofield Energy 
Treated group significantly (p≤0.001) increased the level 
of ALP expression. 
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Group G1 
G2 
1 nM 10 nM 100 nM G3 
Absorbance 
0.212 ± 0.031 0.293 0.287 ± 0.040 0.275 ± 0.045 0.28 
 
± 
  
± 
 
0.028 
  
0.016 
% Cell Proliferation w.r.t. G1 100 138*** 135 129 132*** 
G1: Untreated cells; G2: Positive control (β-Estradiol) at the concentrations of 1, 10, and 100 nM. G3: Biofield Energy 
Treated cells. All the groups were included phenol-free DMEM supplemented with 10% CD-FBS. Values are represented as 
mean ± SD and the experiment was carried out in triplicates. ***p≤0.001 vs G1 (using one-way ANOVA). 
Table 2: Effect of the Biofield Energy Treatment on human bone osteosarcoma cell for the assessment of alkaline 
phosphatase enzyme activity measured at 405 nm.  
 
Assessment of Collagen Synthesis  
Effect of the Biofield Energy Treatment on human 
bone osteosarcoma cell and the level of collagen is 
demonstrated in Table 3. The level of collagen in the 
untreated cells (G1) was 163.9 ± 2.31 µg/mL. Besides, the 
level of collagen synthesis was significantly increased by 
27% in the Biofield Energy Treated group (G3) 
supplement with 10% charcoal-dextran treated fetal 
bovine serum (CD-FBS) compared to the G1 group. The 
positive control (β-estradiol) group (G2) showed a 
significantly increased in the synthesis of collagen by 
19.3%, 10.5%, and 3.0% at the concentrations of 1, 10, 
and 100 nM, respectively compared to the G1 group 
(Table 3). Overall, the Biofield Energy Treated group (G3) 
showed an improve synthesis of collagen in the human 
osteosarcoma cells with respect to all the groups. The 
bone health depends on both the quantity as well as 
quality of bone tissue components. Apart from minerals, 
the osteoblast and osteoclast cells contain collagen that 
has an important role in both health. The stability and 
maturation of collagen in bone occurs in two ways like 
enzymatic (i.e., activation of lysyl oxidase) and non-
enzymatic process through the formation of advanced 
glycation end products (AGE). In disease state like 
osteogenesis imperfecta and osteoporosis there was an 
abnormality of collagen synthesis, stability and 
maturation [35,36]. In this experiment, the Biofield 
Energy Treated group supplemented with CD-FBS was 
found to enhanced the synthesis of collagen, which might 
be due to increase formation of AGE, activation of lysyl 
oxidase or due to post-translational modifications of type 
I collagen. Another literature described that the 
osteoblast differentiation and maturation are crucial 
events in the formation of new bone tissue and for the 
determination of bone quality due to the synthesis of 
collagen [37]. Scientists are very keen to find out the ways 
that can improve collagen synthesis in skeletal disorders 
patients. Biofield Energy had felt under the canopy of 
complementary and alternative therapy and already been 
recommended by National Center for Complementary and 
Alternative Medicine (NCCAM). About 30% US population 
are regularly used this therapy for the prevention and 
treatment of various diseases [38-40]. Besides, here The 
Trivedi Effect® - Consciousness Energy Healing Treatment 
modality showed a significant improvement of collagen 
level in human osteosarcoma cells. Thus, it is assumed 
that The Trivedi Effect® has the potential to improve the 
bone health in various skeletal disorders.  
 
Group G1 
G2 
1 nM 10 nM 100 nM G3 
Collagen (µg/mL) 
163.9 ± 195.7 181.2 168.9 208.3 
2.31 
± ± ± ± 
9.83 4.75 9.01 7.76 
Collagen (%) w.r.t. G1 100 119.3*** 110.5*** 103 127.0*** 
Table 3: Effect of the Biofield Energy Treatment on human bone osteosarcoma cell for the assessment of collagen 
synthesis measured at 540 nm.  
G1: Untreated cells; G2: Positive control (β-Estradiol) at the concentrations of 1, 10, and 100 nM. G3: Biofield Energy Treated 
cells. All the groups were included phenol-free DMEM supplemented with 10% CD-FBS. Values are represented as mean ± SD 
and the experiment was carried out in triplicates. ***p≤0.001 vs G1 (using one-way ANOVA). 
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Conclusion 
The cell viability was assessed using MTT assay in 
human bone osteosarcoma cells and found that Biofield 
Energy Healing showed a significantly increased the bone 
cell proliferation compared to the untreated group (G1). 
Further, the levels of ALP and collagen synthesis were 
significantly increased by 32% and 27%, respectively in 
the Biofield Energy Treated cells (G3) group compared to 
the G1 group. Overall, the Biofield Energy Treatment 
significantly enhanced the bone mineralization and 
differentiation compared to the untreated cells group in 
human bone osteosarcoma cells. In conclusion, The 
Trivedi Effect® - Consciousness Energy Healing Treatment 
might act as an effective bone health enhancer and it can 
be used as a complementary and alternative treatment for 
the prevention of various types of skeletal abnormality 
viz. osteoporosis, limb abnormalities, microcephaly, club 
foot, polydactyly, congenital hip dislocation, cleft hand 
and cleft foot, skull abnormalities, anencephaly, 
syndactyly, encephalocele, etc.  
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